Pms56 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Without Methotrexate in Rheumatoid Arthritis Treatment

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1770
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pms44 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line for the Management of Rheumatoid Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Mean Cost Per Number Needed to Treat With Tocilizumab Plus Methotrexate Versus Abatacept Plus Methotrexate in the Treatment of Rheumatoid Arthritis in Patients Previously Treated With Methotrexate

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2017English

Pms41 - Cost-Effectiveness Analysis of Tofacitinib in Combination With Methotrexate in the Treatment of Moderate to Severe Rheumatoid Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Cost-Effectiveness of Alternative Treatment Sequences in Rheumatoid Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Adalimumab With or Without Methotrexate in Juvenile Rheumatoid Arthritis

New England Journal of Medicine
Medicine
2008English

Effectiveness of Subcutaneously Administered Methotrexate in Patients With Rheumatoid Arthritis

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Cost-Effectiveness of Early Treatment With Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients With Established Rheumatoid Arthritis

Advances in Therapy
MedicinePharmacology
2019English

PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy